Cargando…
Mechanism of KIT gene regulation by GATA1 lacking the N-terminal domain in Down syndrome–related myeloid disorders
Children with Down syndrome (DS) are at high risk of transient abnormal myelopoiesis (TAM) and myeloid leukemia of DS (ML-DS). GATA1 mutations are detected in almost all TAM and ML-DS samples, with exclusive expression of short GATA1 protein (GATA1s) lacking the N-terminal domain (NTD). However, it...
Autores principales: | Kanezaki, Rika, Toki, Tsutomu, Terui, Kiminori, Sato, Tomohiko, Kobayashi, Akie, Kudo, Ko, Kamio, Takuya, Sasaki, Shinya, Kawaguchi, Koji, Watanabe, Kenichiro, Ito, Etsuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708825/ https://www.ncbi.nlm.nih.gov/pubmed/36447001 http://dx.doi.org/10.1038/s41598-022-25046-z |
Ejemplares similares
-
Dyserythropoietic anaemia with an intronic GATA1 splicing mutation in patients suspected to have Diamond‐Blackfan anaemia
por: Kobayashi, Akie, et al.
Publicado: (2022) -
Childhood acute myeloid leukemia with 5q deletion and HNRNPH1-MLLT10 fusion: the first case report
por: Kudo, Ko, et al.
Publicado: (2022) -
BRAF V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis
por: Kudo, Ko, et al.
Publicado: (2022) -
Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with GATA1 mutation
por: Nishinaka-Arai, Yoko, et al.
Publicado: (2020) -
Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome
por: Yamato, Genki, et al.
Publicado: (2021)